BSE filing, NSE: JAYBARMARU. Summary written from the filing by ALFA Finder's alert engine.
Jay Bharat Maruti Ltd: key numbers
- Share price
- ₹121.00
- Market cap
- ₹1,310 Cr
- Revenue (annual)
- ₹2,551 Cr
- Net profit (annual)
- ₹139.7 Cr
- P/E (TTM)
- 8.6×Sector 31.7×
- Promoter holding
- 59.35%+0.00% QoQ
- FII holding
- 1.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jay Bharat Maruti Ltd
All →Jay Bharat Maruti Investor Presentation: Key Takeaways
Q2 FY27 standalone total income Rs 828.68 Cr (+41.97% YoY) and PAT Rs 31.12 Cr (+72.59%, aided by lower tax rate). EBITDA margin compressed to 9.65% from 10.70%.
Jay Bharat Maruti Management Change
Jay Bharat Maruti's board on 2 November 2026 changed designations for senior management and appointed Radhika Khurana as Company Secretary and Compliance Officer, effective 18 December 2026. Mayank Varma and Deepak Gupta also had designation changes effective 2 November 2026.
Jay Bharat Maruti Q2 FY27 Results: Net Profit ₹32 Cr, Up 73.9% YoY
Jay Bharat Maruti Ltd reported revenue from operations of ₹823.4 Cr (+41.3% YoY) and net profit of ₹32 Cr (+73.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹32 Cr · +73.9% YoY
Jay Bharat Maruti Board Meeting Date
Jay Bharat Maruti has scheduled a Board meeting on Nov 2, 2026 to consider Q2/H1 FY27 unaudited results and other matters. Trading window remains closed until Nov 4, 2026.
Jay Bharat Maruti Price Movement Clarification
Jay Bharat Maruti responded to NSE surveillance query stating no material information explains the volume spike. The company confirmed volumes are purely market-driven with no undisclosed UPSI.
Jay Bharat Maruti Other Announcement
Jay Bharat Maruti reported zero requests received for transfer and demat of physical shares under the SEBI special window for Sept–Oct 2026. This is a routine nil compliance return with no business or financial impact.
Other business update announcements
All →Kwality Pharmaceuticals Business Update
Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.
Vishnu Prakash R Punglia Business Update
VPRPL entered an MoU with N.K. Gupta Builders for proposed acquisition at evaluation stage. The deal targets expansion in infrastructure and construction, including Leh & Ladakh.
Tata Consultancy Services Business Update
TCS published its Enterprise AI Study surveying 1,333 leaders across 25 countries on AI adoption. The study highlights productivity as AI's top benefit.
Allied Blenders & Distillers Business Update
ABD recorded its highest-ever monthly sales at over 3.6 million cases in October 2026. Officer's Choice Brandy and Sumo Whisky joined the millionaire club, reaching six brands.
Infrax Renewable Business Update
Infrax Renewable received a Certificate of Appreciation at Bharat RE Summit 2026 for 9,887 rooftop solar installations under PM SURYA GHAR. The recognition affirms the company's operational scale in residential solar.
- rooftop solar installations
- 9887 installations
Angel One Business Update
Angel One reported its October 2026 monthly business metrics, including client base, orders and turnover. Trading activity hit a seven-month high, while cash and commodity market shares moderated.